Plasma Selenium Concentration and Glutathione Peroxidase Activity in Breast Cancer Patients Before and After Chemotherapy

被引:0
作者
Moradi, M. [1 ]
Eftekhari, M. H. [1 ]
Talei, A. [2 ]
机构
[1] Shiraz Univ, Sch Hlth, Dept Nutr, Med Sci, Shiraz, Iran
[2] Shiraz Univ Med Sci, Surg, Shiraz, Iran
关键词
breast cancer; chemotherapy; glutathione peroxidase; selenium;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The chemotherapeutic agents used for treatment of breast cancer are all shown to increase free oxygen radicals and generation of reactive oxygen species. The aim of this study was to evaluate effect of chemotherapy on plasma selenium (Se) concentration and glutathione peroxidase (GPX) activity in breast cancer patients. Materials and Methods: Seventeen women in stage II and III breast cancer were randomly selected from their population. Plasma Se was measured with Graphite furnace atomic absorption spectroscopy and GPX activity in erythrocyte by using spectrophotometric at baseline (before chemotherapy) and after chemotherapy. normally distributed data was expressed as mean +/- standard deviation. Statistical analysis was performed using Paired T- Test. Results: plasma Se concentration before and after chemotherapy was in normal range and no statistically difference was observed (156.23 +/- 25 mu g/L vs. 145.23 +/- 23 mu g/L respectively). After chemotherapy, there was a significant (p< 0.05) higher erythrocyte GPX activity, as compared to initial activity at baseline. (22.28 +/- 4 U/grHb vs. 26.39 +/- 4 U/grHb respectively). Conclusion: This study indicates that sufficient Se could increase GPX activity with have a protective effect against oxidative damages.
引用
收藏
页码:119 / 122
页数:4
相关论文
共 16 条
  • [1] Role of ROS modified human DNA in the pathogenesis and etiology of cancer
    Abdi, S
    Ali, A
    [J]. CANCER LETTERS, 1999, 142 (01) : 1 - 9
  • [2] Antioxidant Supplements, Genetics and Chemotherapy Outcomes
    Ambrosone, Christine B.
    Ahn, Jiyoung
    Schoenenberger, Vreni
    [J]. CURRENT CANCER THERAPY REVIEWS, 2005, 1 (03) : 251 - 258
  • [3] Serum selenium measurements in women with early-stage breast cancer with and without chemotherapy-induced ovarian failure
    Breedlove, Hollie A.
    Smith, Anne M.
    Burk, Raymond F.
    Hill, Kristina E.
    Shapiro, Charles L.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2006, 97 (03) : 225 - 230
  • [4] DECREASED ESSENTIAL ANTIOXIDANTS AND INCREASED LIPID HYDROPEROXIDES FOLLOWING HIGH-DOSE RADIOCHEMOTHERAPY
    CLEMENS, MR
    LADNER, C
    SCHMIDT, H
    EHNINGER, G
    EINSELE, H
    BUHLER, E
    WALLER, HD
    GEY, KF
    [J]. FREE RADICAL RESEARCH COMMUNICATIONS, 1989, 7 (3-6): : 227 - 232
  • [5] Clement IP, 1998, J NUTR, V128, P845
  • [6] LIPID-PEROXIDATION PRODUCTS, AND VITAMIN AND TRACE-ELEMENT STATUS IN PATIENTS WITH CANCER BEFORE AND AFTER CHEMOTHERAPY, INCLUDING ADRIAMYCIN - A PRELIMINARY-STUDY
    FABER, M
    COUDRAY, C
    HIDA, H
    MOUSSEAU, M
    FAVIER, A
    [J]. BIOLOGICAL TRACE ELEMENT RESEARCH, 1995, 47 (1-3) : 117 - 123
  • [7] Selenium metabolism, selenoproteins and mechanisms of cancer prevention: complexities with thioredoxin reductase
    Ganther, HE
    [J]. CARCINOGENESIS, 1999, 20 (09) : 1657 - 1666
  • [8] Jonas CR, 2000, AM J CLIN NUTR, V72, P181
  • [9] PAGLIA DE, 1967, J LAB CLIN MED, V70, P158
  • [10] Patrick Lyn, 2004, Altern Med Rev, V9, P239